On Air Now

Tune in to Listen

93.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
49° Feels Like: 49°
Wind: NNW 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

AM Clouds/PM Sun 53°

Tonight

Clear 28°

Tomorrow

Sunny 58°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Roche says EU panel backs lymphatic cancer drug for approval

ZURICH (Reuters) - Swiss drug company Roche said on Friday a European Union committee recommended its MabThera subcutaneous treatment for patients with non-Hodgkin lymphoma.

Roche said the opinion of the EU Committee for Medicinal Products for Human Use (CHMP) was based primarily on data from a phase III study, with a final decision from the European Commission expected in coming months.

The Commission generally follows committee recommendations, though it is not obliged to.

MabThera is a treatment for non-Hodgkin lymphoma, a cancer of the lymphatic system, and is currently delivered by an intravenous infusion which takes 2-1/2 hours to complete.

In contrast, the new MabThera subcutaneous formulation can be delivered over approximately five minutes, Roche said.

(Reporting by Alice Baghdjian)

Comments